Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities - a Randomized Controlled Parallel Assigned Study
Condition:   Major Depressive Disorder Interventions:   Drug: Vortioxetine;   Drug: Venlafaxine Sponsors:   Scotmann Pharmaceuticals;   Rawalpindi Medical College Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2021 Category: Research Source Type: clinical trials

The Use of Venlafaxine in Reducing Pain in Primary Total Knee Replacement
Conditions:   Acute Pain;   Chronic Pain;   Knee Pain Chronic;   Neuropathic Pain Interventions:   Drug: Venlafaxine 37.5 MG;   Drug: Placebo Sponsors:   University of California, San Francisco;   Orthopedic Research and Education Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2021 Category: Research Source Type: clinical trials